Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million

- Strengthened balance sheet to fully fund development and launch of NXT-41 platform -

- Biologics for breast reconstruction represents $1.5 billion U.S. total addressable market -

Read more at globenewswire.com